Back to HomeBeta

ICD-10 Coding for Metastatic Squamous Cell Carcinoma(C79.8, C80.1)

Complete ICD-10-CM coding and documentation guide for Metastatic Squamous Cell Carcinoma. Includes clinical validation requirements, documentation requirements, and coding pitfalls.

Also known as:

Metastatic SCCSecondary Squamous Cell Carcinoma

Related ICD-10 Code Ranges

Complete code families applicable to Metastatic Squamous Cell Carcinoma

C79-C80Primary Range

Secondary malignant neoplasms and unspecified malignant neoplasms

This range includes codes for secondary malignant neoplasms, which are relevant for coding metastatic squamous cell carcinoma.

Other malignant neoplasms of skin

This range includes codes for primary squamous cell carcinoma of the skin, which may be relevant when identifying the primary site.

Code Comparison: When to Use Each Code

Compare key differences between these codes to ensure accurate selection

CodeDescriptionWhen to UseKey Documentation
C79.8Secondary malignant neoplasm of other specified sitesUse when squamous cell carcinoma has metastasized to a specific site.
  • Histologic confirmation of SCC in metastatic site
  • Radiologic correlation (CT/MRI showing lesion)
  • IHC markers confirming epithelial origin (CK5/6, p40)
C80.1Malignant (primary) neoplasm, unspecifiedUse when the primary site of the malignancy is unknown.
  • Negative full skin exam report
  • PET-CT showing no primary lesion
  • Endoscopic evaluation when applicable

Clinical Decision Support

Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.

Key Information: ICD-10 code for metastatic squamous cell carcinoma

Essential facts and insights about Metastatic Squamous Cell Carcinoma

Metastatic squamous cell carcinoma is coded as C79.8 for secondary sites, with C80.1 for unknown primary.

Primary ICD-10-CM Codes for metastatic squamous cell carcinoma

Secondary malignant neoplasm of other specified sites
Non-billable Code

Decision Criteria

clinical Criteria

  • Histological confirmation of metastatic SCC

documentation Criteria

  • Clear documentation of metastatic site

Applicable To

  • Metastatic squamous cell carcinoma to specific sites

Excludes

  • Primary malignant neoplasms

Clinical Validation Requirements

  • Histologic confirmation of SCC in metastatic site
  • Radiologic correlation (CT/MRI showing lesion)
  • IHC markers confirming epithelial origin (CK5/6, p40)

Code-Specific Risks

  • Ensure primary site is documented if known to avoid incorrect coding.

Coding Notes

  • Ensure documentation clearly states the metastatic nature and site.

Ancillary Codes

Additional codes that should be used in conjunction with the main diagnosis codes when applicable.

Personal history of squamous cell carcinoma

Z85.810
Use to indicate a history of squamous cell carcinoma.

Differential Codes

Alternative codes to consider when ruling out similar conditions to the primary diagnosis.

Malignant (primary) neoplasm, unspecified

C80.1
Use C80.1 when the primary site is unknown or not documented.

Secondary malignant neoplasm of other specified sites

C79.8
Use C79.8 when the metastatic site is specified.

Documentation & Coding Risks

Avoid these common documentation and coding issues when documenting Metastatic Squamous Cell Carcinoma to ensure proper reimbursement, maintain compliance, and reduce audit risk. These guidelines are particularly important when using ICD-10 code C79.8.

Impact

Clinical: May lead to inappropriate treatment plans., Regulatory: Non-compliance with coding standards., Financial: Potential for claim denials.

Mitigation Strategy

Thorough review of patient history, Cross-reference with imaging and pathology

Impact

Reimbursement: Incorrect coding can lead to claim denials., Compliance: Non-compliance with coding guidelines., Data Quality: Inaccurate data on cancer incidence and treatment.

Mitigation Strategy

Use C77.0 for lymph node metastasis and C80.1 if primary is unknown.

Impact

Risk of incorrect coding of metastatic sites without primary site documentation.

Mitigation Strategy

Ensure thorough documentation and cross-verification with imaging and pathology.

Documentation errors, coding pitfalls, and audit risks are interconnected aspects of medical coding and billing. Addressing all three areas helps ensure accurate coding, optimal reimbursement, and regulatory compliance.

Frequently Asked Questions

Common questions about ICD-10 coding for Metastatic Squamous Cell Carcinoma, with expert answers to help guide accurate code selection and documentation.

Documentation Templates for Metastatic Squamous Cell Carcinoma

Use these documentation templates to ensure complete and accurate documentation for Metastatic Squamous Cell Carcinoma. These templates include all required elements for proper coding and billing.

Metastatic SCC to lung with unknown primary

Specialty: Oncology

Required Elements

  • Histological confirmation
  • Imaging results
  • Treatment plan

Example Documentation

Metastatic squamous cell carcinoma to right lung (C78.02), primary site undetermined.

Examples: Poor vs. Good Documentation

Poor Documentation Example
SCC with spread to bone
Good Documentation Example
Metastatic moderately differentiated squamous cell carcinoma to L3 vertebral body, primary origin in left posterior scalp (C44.229), confirmed via CK5/6+ and p40+ IHC staining
Explanation
The good example provides specific details about the primary and metastatic sites, along with histological confirmation.

Need help with ICD-10 coding for Metastatic Squamous Cell Carcinoma? Ask your questions below.

Ask about any ICD-10 CM code, or paste a medical note

We build tools for
clinician happiness.

Learn More at Freed.ai
Back to HomeBeta

Built by Freed

Try Freed for free for 7 days.

Learn more